β-amyloid (A β)
Decreased levels of soluble amyloid β protein precursor and β amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus
8
Modulation of β-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family
13
β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice
11
Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer’s disease mouse model
10
Prophylactic melatonin significantly reduces Alzheimer’s neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPPswe/PS1 mice
21
Cross-talk of membrane lipids and Alzheimer-related proteins
12
Cerebral amyloid angiopathy-related inflammation: a case report presenting with a rare variant in SORL1 gene
6
APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment
10
Crystal structure reveals conservation of amyloid-β conformation recognized by 3D6 following humanization to bapineuzumab
13
Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment
15
Identification of the novel activity-driven interaction between synaptotagmin 1 and presenilin 1 links calcium, synapse, and amyloid beta
24
Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer’s disease
12
Decreasing the expression of PICALM reduces endocytosis and the activity of β secretase: Implications for Alzheimer's disease
17
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
15
Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer’s disease and transgenic mouse models
12
Calcium/calmodulin-dependent kinase II and Alzheimer’s disease
7
Cell adhesion molecules in Alzheimer's disease
13
Adult hippocampal neurogenesis and its role in Alzheimer's disease
9
Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent
11
RIG-1 receptor expression in the pathology of Alzheimer’s disease
9